[go: up one dir, main page]

BE2011C013I2 - - Google Patents

Info

Publication number
BE2011C013I2
BE2011C013I2 BE2011C013C BE2011C013C BE2011C013I2 BE 2011C013 I2 BE2011C013 I2 BE 2011C013I2 BE 2011C013 C BE2011C013 C BE 2011C013C BE 2011C013 C BE2011C013 C BE 2011C013C BE 2011C013 I2 BE2011C013 I2 BE 2011C013I2
Authority
BE
Belgium
Prior art keywords
formulations
controlling
animal
dose
provides
Prior art date
Application number
BE2011C013C
Other languages
French (fr)
Original Assignee
Elanco Us Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22526570&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BE2011C013(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Elanco Us Inc filed Critical Elanco Us Inc
Publication of BE2011C013I2 publication Critical patent/BE2011C013I2/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
    • A01N43/22—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom rings with more than six members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Dentistry (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Environmental Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)

Abstract

The invention provides single-dose oral formulations for controlling an ectoparasite infestation on a companion animal for a prolonged time, said formulations comprising a spinosyn component, or a physiologically acceptable derivative or salt thereof, and a carrier in oral dosage form. It also provides methods for controlling such infestations comprising orally administering a single dose of these formulations to the animal.
BE2011C013C 1999-08-12 2011-05-24 BE2011C013I2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14861899P 1999-08-12 1999-08-12
EP00955247A EP1207756B1 (en) 1999-08-12 2000-08-02 Use of spinosad or a formulation comprising spinosad
PCT/US2000/019557 WO2001011963A1 (en) 1999-08-12 2000-08-02 Oral treatment of companion animals with ectoparasiticidal spinosyns

Publications (1)

Publication Number Publication Date
BE2011C013I2 true BE2011C013I2 (en) 2019-10-16

Family

ID=22526570

Family Applications (1)

Application Number Title Priority Date Filing Date
BE2011C013C BE2011C013I2 (en) 1999-08-12 2011-05-24

Country Status (25)

Country Link
US (1) US6664237B1 (en)
EP (1) EP1207756B1 (en)
JP (2) JP5046455B2 (en)
KR (1) KR100706146B1 (en)
AT (1) ATE324039T1 (en)
AU (1) AU775488B2 (en)
BE (1) BE2011C013I2 (en)
BR (1) BR0013116B1 (en)
CA (1) CA2379329C (en)
CO (1) CO5410187A1 (en)
CY (1) CY1105000T1 (en)
DE (2) DE60027575T2 (en)
DK (1) DK1207756T3 (en)
ES (1) ES2261229T3 (en)
FR (1) FR11C0017I2 (en)
HU (1) HUP0202825A2 (en)
IL (2) IL147828A0 (en)
MX (1) MXPA02001505A (en)
MY (1) MY125485A (en)
NO (1) NO20020686L (en)
NZ (1) NZ516790A (en)
PT (1) PT1207756E (en)
TW (1) TWI244373B (en)
WO (1) WO2001011963A1 (en)
ZA (1) ZA200200565B (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6933318B1 (en) 1999-08-12 2005-08-23 Eli Lilly And Company Topical organic ectoparasiticidal formulations
AUPQ441699A0 (en) 1999-12-02 2000-01-06 Eli Lilly And Company Pour-on formulations
DE10135550A1 (en) * 2001-07-20 2003-01-30 Bayer Cropscience Ag Process for the preparation of new spinosyn derivatives
SK1282004A3 (en) 2001-09-17 2004-08-03 Lilly Co Eli Pesticidal formulations
EP1682118B1 (en) * 2003-11-04 2008-10-22 Intervet International BV Ectoparasiticidal formulations of spinosyns and azole pesticides
CN102558082B (en) 2004-03-05 2015-09-30 日产化学工业株式会社 Isoxazoline-substituted benzamide compound prepare intermediate
SG159395A1 (en) * 2004-04-29 2010-03-30 Lilly Co Eli Use of spinosyns for wound healing
ATE454156T1 (en) 2004-04-29 2010-01-15 Lilly Co Eli SPINOSYNE FOR WOUND HEALING
AU2006249441A1 (en) 2005-05-26 2006-11-30 Eli Lilly And Company Improved fish production
KR100855417B1 (en) * 2006-10-27 2008-08-29 일라이 릴리 앤드 캄파니 Pharmaceutical composition for wound healing containing spinocin
KR101769728B1 (en) 2007-06-27 2017-08-18 이 아이 듀폰 디 네모아 앤드 캄파니 Animal pest control method
US9820977B2 (en) 2008-10-03 2017-11-21 Bayer Healthcare Llc Systemic treatment of blood-sucking and blood-consuming parasites by oral administration of a parasiticidal agent
AU2013273709B2 (en) * 2009-05-08 2015-04-23 Eli Lilly And Company Ectoparasiticidal methods and formulations
UA108200C2 (en) * 2009-05-08 2015-04-10 MEDICINAL FORMS AND METHODS FOR THE USE OF ECTOPAROSITOCIDES
TWI510189B (en) * 2009-06-19 2015-12-01 Lilly Co Eli Ectoparasiticidal methods and formulations
CA2764526A1 (en) 2009-06-24 2010-12-29 Christine Kritikou The use of spinosyns and spinosyn compositions against diseases caused by protozoans, viral infections and cancer
WO2011091122A1 (en) * 2010-01-25 2011-07-28 Eli Lilly And Company Methods for internally controlling or treating equine bot larvae
WO2012061807A1 (en) * 2010-11-05 2012-05-10 Eli Lilly And Company Methods for inhibiting insect infestations
ITMI20111945A1 (en) * 2011-10-26 2013-04-27 Zapi Ind Chimiche Spa FORMULATION IN A SUITABLE FORM TO VEHICLE A DOSED QUANTITY OF AN ACTIVE SUBSTANCE
CN103125501A (en) * 2011-11-30 2013-06-05 上海农乐生物制品股份有限公司 Abamectin-spinosad emulsion in water and preparing method thereof
TW201416077A (en) * 2012-07-26 2014-05-01 Lilly Co Eli Single dose oral formulations and methods for treatment of cats with ectoparasiticidal spinosad
ES2898617T3 (en) 2012-11-14 2022-03-08 Elanco Us Inc Ectoparasiticidal methods and formulations comprising spinetoram
WO2020012406A1 (en) * 2018-07-11 2020-01-16 Jubilant Generics Limited Veterinary dosage forms
CN109221133A (en) * 2018-09-28 2019-01-18 绩溪农华生物科技有限公司 A kind of Pleocidin synergistic aqueous emulsion and preparation method thereof
JP2024513690A (en) * 2021-03-11 2024-03-27 イン ザ ボウル アニマル ヘルス，インコーポレーテッド Methods for controlling flea and tick infestations in mammals - Patents.com
WO2022192614A1 (en) * 2021-03-11 2022-09-15 In The Bowl Animal Health, Inc. Oral canine feed and methods for controlling flea infestations in a canine
EP4304605A4 (en) * 2021-03-11 2025-01-22 In the Bowl Animal Health, Inc. FOOD AND METHODS FOR CONTROLLING TICK INFECTION IN A MAMMAL
WO2022271937A2 (en) * 2021-06-25 2022-12-29 In The Bowl Animal Health, Inc. Oral feline feed and methods for controlling flea infestations in a feline
CN118055703A (en) * 2021-06-25 2024-05-17 碗中动物健康公司 Feline oral feed and method of controlling flea infestation in felines

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US576253A (en) * 1897-02-02 Manhole-cover
US5362634A (en) 1989-10-30 1994-11-08 Dowelanco Process for producing A83543 compounds
PE5591A1 (en) * 1988-12-19 1991-02-15 Lilly Co Eli A NEW GROUP OF MACROLIDA COMPOUNDS
JPH0375316A (en) * 1989-08-18 1991-03-29 Tokyo Gas Denro Kk Heat treatment furnace
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
US5539089A (en) 1991-11-08 1996-07-23 Dowelanco A83543 aglycones and pseudoglycones
US5202242A (en) 1991-11-08 1993-04-13 Dowelanco A83543 compounds and processes for production thereof
US5227295A (en) 1991-11-08 1993-07-13 Dowelanco Process for isolating A83543 and its components
US5591606A (en) 1992-11-06 1997-01-07 Dowelanco Process for the production of A83543 compounds with Saccharopolyspora spinosa
ES2099604T3 (en) 1993-03-12 1997-05-16 Dowelanco NEW A83543 COMPOUNDS AND PROCEDURE FOR ITS PRODUCTION.
EP0837870B1 (en) 1995-06-14 2002-07-24 Dow AgroSciences LLC Synthetic modification to spinosyn compounds
US5695776A (en) 1996-03-12 1997-12-09 Fmc Corporation Termite bait apparatus having grooves
US6001981A (en) * 1996-06-13 1999-12-14 Dow Agrosciences Llc Synthetic modification of Spinosyn compounds
GB9624501D0 (en) * 1996-11-26 1997-01-15 Zeneca Ltd Insecticial compositions and method
JPH11139912A (en) * 1997-11-06 1999-05-25 Nissan Chem Ind Ltd Stabilized agrochemical composition
NZ525906A (en) * 1997-12-23 2005-03-24 Syngenta Participations Ag Use of the macrolides abamectin, emamectin, and spinosad in pest control for protecting plant propagation material
SK20062000A3 (en) 1998-07-02 2002-02-05 Eli Lilly And Company Formulations for controlling human lice
WO2000060940A1 (en) 1999-04-12 2000-10-19 Dow Agrosciences Llc Aqueous dispersions of agricultural chemicals
WO2001012156A1 (en) 1999-08-12 2001-02-22 Eli Lilly And Company Topical organic ectoparasiticidal formulations
WO2001011961A1 (en) 1999-08-12 2001-02-22 Eli Lilly And Company Control of ectoparasites using spinosyns
EP1212337B1 (en) 1999-09-13 2004-10-20 Dow AgroSciences LLC Pesticidal macrolides
AUPQ441699A0 (en) 1999-12-02 2000-01-06 Eli Lilly And Company Pour-on formulations

Also Published As

Publication number Publication date
DE60027575T2 (en) 2007-02-15
PT1207756E (en) 2006-07-31
WO2001011963A1 (en) 2001-02-22
MXPA02001505A (en) 2002-07-02
IL147828A (en) 2006-08-20
IL147828A0 (en) 2002-08-14
NO20020686L (en) 2002-04-09
FR11C0017I1 (en) 2011-08-07
JP2012001563A (en) 2012-01-05
CO5410187A1 (en) 2004-06-30
ATE324039T1 (en) 2006-05-15
BR0013116A (en) 2002-04-30
TWI244373B (en) 2005-12-01
DE122011100022I1 (en) 2011-10-20
EP1207756A1 (en) 2002-05-29
US6664237B1 (en) 2003-12-16
JP5046455B2 (en) 2012-10-10
KR20020032550A (en) 2002-05-03
MY125485A (en) 2006-08-30
CY1105000T1 (en) 2010-03-03
JP5427217B2 (en) 2014-02-26
FR11C0017I2 (en) 2012-06-15
HUP0202825A2 (en) 2003-03-28
DK1207756T3 (en) 2006-08-14
ES2261229T3 (en) 2006-11-16
KR100706146B1 (en) 2007-04-11
AU775488B2 (en) 2004-08-05
CA2379329A1 (en) 2001-02-22
BR0013116B1 (en) 2013-01-22
AU6747600A (en) 2001-03-13
NO20020686D0 (en) 2002-02-11
ZA200200565B (en) 2003-11-26
JP2003506463A (en) 2003-02-18
NZ516790A (en) 2003-03-28
CA2379329C (en) 2009-10-20
EP1207756B1 (en) 2006-04-26
DE60027575D1 (en) 2006-06-01

Similar Documents

Publication Publication Date Title
BE2011C013I2 (en)
WO2000041681A3 (en) MEDICINAL FORMULATIONS CONTAINING AN OPIOID AND AN α-ANTAGONIST
UA84266C2 (en) Oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyroolidon as excipient, processes for the preparation and use thereof
WO2002019969A3 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
GEP20053473B (en) High Potency Dihydroergotamine Compositions
NZ516347A (en) Indanyl-substituted benzenecarboxamides, process for their preparation, their use as a medicament and pharmaceutical formulations containing them
ZA200606173B (en) Effervescent oral opiate dosage form
IL133397A0 (en) Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin
ATE287264T1 (en) ORAL MEDICINAL PRODUCTS CONTAINING BUPRENORPHINE
WO2001082897A3 (en) Liposome drug delivery
DE59907481D1 (en) CONTROLLING RELEASING PHARMACEUTICAL COMPOSITION WITH TILIDINE MESYLATE AS AN ACTIVE SUBSTANCE
CA2489140A1 (en) Dosage form containing pantoprazole as active ingredient
WO2005065639A3 (en) Novel pharmaceutical compositions
WO2004098577A3 (en) Dosage form containing (s)-pantoprazole as active ingredient
CA2385755A1 (en) Prevention of colorectal cancer
SI1558219T1 (en) Pharmaceutical formulation of olanzapine
EP1273301A3 (en) Pharmaceutical preparations based on active ingredients susceptible to illict administration
WO2001066102A3 (en) Oral dosage form for administration of the combination of tegafur, uracil, folinic acid, and oxaliplatin and method of using the same
PL368040A1 (en) Substituted 4-aminocyclohexanol derivatives
CA2409845A1 (en) Active substance combination containing a compound with an opioid effect and at least one further compound of formula i
TH32452A (en) Deodorant
UA27784C2 (en) Effervescent pharmaceutical composition for oral use
TH69069A (en) Treatment of pest infestations in pets by giving them by mouth.